Anebulo Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Accrued Expenses

12 Months Ended

Jun. 30, 2022

Note 5. Accrued Expenses

Accrued expenses consisted of the following:

Schedule of Accrued Expenses


	June 30,
	2022		2021
Accrued research and development	$	105,980	$	121,662
Accrued paid time off		25,723		-
Accrued legal		-		9,923
Total accrued expenses	$	131,703	$	131,585